Stay updated on MIW815 +/- Ipilimumab in Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the MIW815 +/- Ipilimumab in Solid Tumors Clinical Trial page.

Latest updates to the MIW815 +/- Ipilimumab in Solid Tumors Clinical Trial page
- Check4 days agoChange DetectedThe page displays Revision: v3.6.3 instead of v3.6.2, representing a small update to the page's revision history.SummaryDifference0.1%

- Check11 days agoChange DetectedThe page now displays revision v3.6.2 instead of v3.6.0, indicating a small internal update to the page template. It does not reflect changes to the study data or visible functionality for users.SummaryDifference0.1%

- Check18 days agoNo Change Detected
- Check26 days agoChange DetectedRecruitment status updated to No longer looking for participants, indicating enrollment is closed. Header formatting changed from 'Intervention / Treatment' to 'Intervention/Treatment,' and new help/navigation sections were added (How to Read a Study Record, Common Questions, How to Join a Study) along with a revision note (Revision: v3.6.0) replacing the prior version (Revision: v3.5.5).SummaryDifference0.6%

- Check33 days agoChange DetectedA new revision tag v3.5.5 was added, replacing the previous v3.5.4, indicating a minor update to the study record's documentation.SummaryDifference0.1%

- Check54 days agoChange DetectedA new revision tag (v3.5.4) now appears on the page, indicating a minor update to the record's metadata. The substantive study details and eligibility criteria appear unchanged.SummaryDifference0.1%

- Check76 days agoChange DetectedThe page footer revision was updated from v3.5.2 to v3.5.3, indicating a site/version change rather than an update to the clinical trial record itself.SummaryDifference0.1%

Stay in the know with updates to MIW815 +/- Ipilimumab in Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the MIW815 +/- Ipilimumab in Solid Tumors Clinical Trial page.